Surgery Partners’ net loss widens 500% in Q2 

Advertisement

Surgery Partners’ net loss attributable to the company jumped to $15 million in the second quarter, a 500% increase from a $2.5 million loss in the same period last year, even as revenue grew 2.7% to $848.9 million, the Brentwood, Tenn.-based company said in an Aug. 10 news release.

Here are 10 things to know:

1. Net loss attributable to Surgery Partners was $15 million for the second quarter, up from $2.5 million a year earlier. 

2. Revenue for the quarter was $848.9 million, up 2.7% from $826 million in the second quarter of 2025.

3. Same-facility revenue rose 5% year over year, driven by a 4.8% increase in revenue per case and a 0.3% increase in same-facility cases.

4. Adjusted EBITDA was $125.2 million for the quarter, down from $129 million in the same period last year; adjusted EBITDA margin slipped to 14.7% from 15.6%.

5. Year-to-date revenue was $1.66 billion, up 3.6% from $1.6 billion in the 2025 period. 

6. Year-to-date adjusted EBITDA was $227.5 million, down from $232.9 million.

7. The company reaffirmed full-year 2026 guidance of $3.35 billion to $3.45 billion in revenue and adjusted EBITDA of at least $530 million, excluding its pending Idaho Falls, Idaho, divestiture. Surgery Partners is pursuing the sale of its ownership interests in Mountain View Hospital and Idaho Falls Community Hospital to Intermountain Health. The deal remains subject to closing conditions, including physician member and governing board approvals.

8. The company operated 178 surgical facilities as of June 30, including 120 consolidated facilities, up from 162 total facilities (115 consolidated) a year earlier.

9. Surgery Partners had $216.7 million in cash and cash equivalents and $617.8 million of borrowing capacity under its revolving credit facility as of June 30. Its net debt-to-EBITDA ratio was about 4.4x.

10. CEO Eric Evans said in the release that the quarter reflected “disciplined execution” against the company’s strategic priorities and pointed to the Idaho Falls deal as “an important step forward” in its portfolio optimization strategy. 

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement